Mike Mike

Pediatric Neurologist and Epileptologist with extensive experience in neurological assessments and treatment. Goal driven for enhancing patient care through innovation and tailored therapeutic approaches. Highly collaborative, adaptable to changing clinical environments, and committed to achieving optimal patient outcomes.

• Board Certification, American Osteopathic Board of Neurology and Psychiatry
• Diplomate, National Board of Osteopathic Medical Examiners
• Good Clinical Practice training via Collaborative Institutional Research Initiative (CITI)
• Licensed physician in California and Arizona

• 2014-2015 Co-author for Pediatric Neurology section of Medical textbook for University of Hawaii School of Medicine.
• Aug 2004 “Tics and Tourette Syndrome” Newsletter and Website Article Article on website and monthly newsletter of California Pacific Medical Center, informing pediatricians of new treatments and research.
• 2002-2003 Assistant reviewer for journal, Epilepsia, under senior editor at Stanford University Medical Center
• 2000-2002 Study investigating risk factors for post cardiac transplant seizures in infants with hypoplastic left heart syndrome. Published Pediatric Neurology. Vol. 28 No. 5. pp. 370-378.
• 2001 Study on the utility of Magnetic Resonance Spectroscopy in patients with Subacute Sclerosing Panencephalitis. This was presented in poster format at the 69th Annual Postgraduate Convention at the Loma Linda University School of Medicine.

• Feb. 2009-2019 Adjunct Assistant Professor Touro University Nevada
• Jan. 2009-2019 Co-medical Director Nevada Neurosciences Epilepsy Center Sunrise Hospital and Medical Center, Las Vegas, NV
• Apr. 2010-2012 Clinical Assistant Professor University of Nevada School of Medicine
• May 2007-July 2008 Clinical Instructor University of California, San Francisco School of Medicine

• 2017-2019: PI, Phase III trial of Parampanel for partial onset seizures
• 2013-2019: PI, Phase II and III trials of Use of Anti-epileptic drug, Lacosamide, as in pediatric epilepsy
• 2016-2017: PI, Phase I, II, III trial of Use of Cannabidiol as add-on for epilepsy
• 2014-2016: PI, Phase III trial of Melatonin in Sleep disturbance and Autism
• 2012-2013: PI, Phase II trial of Use of Memantine in with Autism
• 2002: Sub-investigator, Anti-epileptic drug; Talampanel Stanford University
• 1992-1993 Performed research under David Gough, Ph.D., chairman of the Department of Bioengineering at the University of California, San Diego. This research involved comparisons of various formulations of synthetic bone cement improved

• 2021-2022 Covid-19 Vaccination Program Consultant
• 2002-2019 Epilepsy Foundation of America Northern California and Southern Nevada Chapters Involved with community outreach activities and patient educational conferences.
• 2015-2019 AzulBlue Autism Support Group Involved with community outreach activities and patient educational conferences.
• 2012-2013 Credential Committee Member at Dignity Health St. Rose Dominican Hospital.
• 2005- 2008 Review Board Member for The Permanente Journal (a peer-reviewed journal of medical science, social science in medicine, and medical humanities)
• 2000-2001 Step III Licensing Examination Test Item Writer Activities include writing questions for NBOME Step 3 examination, and overseeing and critiquing test items from co-authors.